Markets:

Overview

News

Currencies

International

Treasuries

Vaxcyte, Inc. - Common Stock (NQ:PCVX)

58.39 +2.31 (+4.12%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vaxcyte, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Why Vaxcyte Shares Are Trading Sharply Higher? Here Are 63 Stocks Moving In Monday's Mid-Day Session ↗

October 24, 2022

Gainers Vaxcyte, Inc. (NASDAQ: PCVX) shares jumped 65% to $33.96 after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety,...

Via Benzinga

Nasdaq Turns Higher; Applied Genetic Technologies Shares Surge ↗

October 24, 2022

U.S. stocks traded mostly higher midway through trading, with the Dow Jones surging more than 300 points on Monday.

Via Benzinga

Earnings Scheduled For February 28, 2022 ↗

February 28, 2022

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...

Via Benzinga

Vaxcyte Shares Surge As Its Pneumococcal Vaccine On Par With Pfizer's Shot In Study ↗

October 24, 2022

Via Benzinga

Why Is Tricida (TCDA) Stock Down 90% Today? ↗

October 24, 2022

Tricida (TCDA) stock is falling on Monday following the release of poor results from a Phase 3 chronic kidney disease clinical trial.

Via InvestorPlace

How Is The Market Feeling About Vaxcyte? ↗

October 24, 2022

Vaxcyte's (NASDAQ:PCVX) short percent of float has risen 22.85% since its last report. The company recently reported that it has 2.48 million shares sold short, which is 5.43% of all regular shares...

Via Benzinga

Why Is Vaxcyte (PCVX) Stock Up 70% Today? ↗

October 24, 2022

Vaxcyte (PCVX) stock is rocketing higher on Monday after the vaccine company revealed positive data from a Phase 1/2 clinical trial.

Via InvestorPlace

US Stocks Mixed; Dow Jumps 200 Points ↗

October 24, 2022

U.S. stocks traded mixed this morning, with the Dow Jones surging around 200 points on Monday.

Via Benzinga

Vaxcyte Shares Are Soaring: Here's Why ↗

October 24, 2022

Vaxcyte Inc (NASDAQ: PCVX) shares are trading higher Monday after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety, tolerability...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 24, 2022

Gainers Applied Genetic Techs (NASDAQ:AGTC) shares moved upwards by 62.0% to $0.39 during Monday's pre-market session. The company's market cap stands at $26.3 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

October 24, 2022

Good morning, traders! We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning!

Via InvestorPlace

Vaxcyte Reports Positive Topline Data from Phase 1/2 Proof-of-Concept Study of its 24-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Pneumococcal Disease in Adults Aged 18-64

October 24, 2022

From Vaxcyte, Inc.

Via GlobeNewswire

Vaxcyte to Host Webcast and Conference Call to Discuss Topline Results from the Phase 1/2 Proof-of-Concept Study of VAX-24 Being Investigated for the Prevention of Invasive Pneumococcal Disease in Adults

October 23, 2022

From Vaxcyte, Inc.

Via GlobeNewswire

Vaxcyte Expands Executive Leadership Team with Key Appointments

October 11, 2022

From Vaxcyte, Inc.

Via GlobeNewswire

Vaxcyte Completes Enrolment In Mid-Stage Pneumococcal Disease Study, Sees Top-line Data In H1 2013 ↗

September 06, 2022

Vaxcyte (NASDAQ: PCVX) has completed patient enrollment in the Phase 2 study evaluating VAX-24 in healthy adults 65 years of age and older. VAX-24 is its lead, 24-valent pneumococcal conjugate vaccine...

Via Benzinga

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗

August 04, 2022

The European Commission (EC) has approved AstraZeneca (NASDAQ: AZN) and Merck’s (NYSE: MRK) LYNPARZA as monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients...

Via Benzinga

Vaxcyte Concludes Enrolment In Mid-Stage Pneumococcal Disease Study ↗

July 12, 2022

Vaxcyte (NASDAQ: PCVX) completed patient enrollment in the Phase 2 portion of the ongoing Phase 1/2 proof-of-concept study evaluating VAX-24 in healthy adults 50 to 64 years of age.

Via Benzinga

48 Biggest Movers From Yesterday ↗

January 14, 2022

Gainers Singularity Future Technology Ltd. (NASDAQ: SGLY) shares rose 25.9% to settle at $5.01 on Thursday. MedAvail Holdings, Inc (NASDAQ: MDVL) gained 24.4% to settle at $1.58...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 13, 2022

Gainers Stealth BioTherapeutics (NASDAQ:MITO

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 13, 2022

Gainers Rockwell Medical (NASDAQ:RMTI) st...

Via Benzinga

26 Stocks Moving In Thursday's Mid-Day Session ↗

January 13, 2022

Gainers Dave Inc. (NASDAQ: DAVE) gained 29.4% to $6.73. Takung Art Co., Ltd. (NASDAQ: TKAT) shares gained 18.6% to $4.1499. Traders are circulating earlier news that China is...

Via Benzinga

The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact ↗

January 13, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Says Lead Monoclonal Antibody Effective Against Omicron Variant Adagio...

Via Benzinga

Vaxcyte Raises $100M Via Equity To Fund Development Of Lead Pneumococcal Vaccine Candidate ↗

January 13, 2022

Vaxcyte Inc (NASDAQ: PCVX) priced its previously announced offering of common stock and pre-funded warrants at $20.00 per share, and $19.999 per underlying share,...

Via Benzinga

20 Stocks Moving in Thursday's Pre-Market Session ↗

January 13, 2022

Gainers BTCS Inc. (NASDAQ: BTCS) rose 41% to $9.45 in pre-market trading after jumping 19% on Wednesday. Adagio Therapeutics, Inc. (NASDAQ: ADGI) rose 22.8% to $7.16 in pre-...

Via Benzinga

A Peek Into The Markets: US Stock Futures Mostly Flat Ahead Of PPI, Jobless Claims ↗

January 13, 2022

Pre-open movers U.S. stock futures traded mostly flat in early pre-market trade after closing slightly higher in the previous session. Investors are awaiting earnings results from...

Via Benzinga

5 Stocks To Watch For January 13, 2022 ↗

January 13, 2022

Some of the stocks that may grab investor focus today are: Wall Street expects Delta Air Lines, Inc. (NYSE: DAL) to report quarterly earnings at $0.13 per share on revenue of $...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 12, 2022

Gainers Biomerica (NASDAQ:BMRA) stock inc...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 29, 2021

Gainers Biofrontera (NASDAQ:

Via Benzinga

Wingstop, Akamai Initiations Among Today's Top Calls On Wall Street ↗

December 29, 2021

Benchmark analyst Todd Brooks initiated coverage of Wingstop (WING) with a Hold rating and no price target. The analyst believes the stock's risk/reward is balanced at these levels given the current

Via Talk Markets

46 Biggest Movers From Yesterday ↗

August 19, 2021

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% on Tuesday. SGOCO Group, Ltd. (NASDAQ: SGOC) surged 67...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.